Adelman Burt A Insider Trades

Insider Trading History

Track insider trading activity for Adelman Burt A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Verve Therapeutics
Verve Therapeutics VERV
Director
Holding Value $0 0 shares
Last Trade
Jul 25, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$4.5M 428,326 shares
$10.50
$11.13
Verve Therapeutics
Verve Therapeutics VERV
Director
Holding Value $0 0 shares
Last Trade
Jul 25, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.47M 221,537 shares
$11.13
$11.13
Verve Therapeutics
Verve Therapeutics VERV
Director
Holding Value $470k 42,200 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$242k 42,200 shares
$5.73
$11.13
Verve Therapeutics
Verve Therapeutics VERV
Director
Holding Value $1.52M 136,139 shares
Last Trade
Jun 26, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$683k 136,139 shares
$5.02
$11.13
Verve Therapeutics
Verve Therapeutics VERV
Director
Holding Value $297k 26,642 shares
Last Trade
Jun 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$529k 26,642 shares
$19.84
$11.13
Verve Therapeutics
Verve Therapeutics VERV
Director
Holding Value $173k 15,500 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$218k 15,500 shares
$14.04
$11.13
Verve Therapeutics
Verve Therapeutics VERV
Director
Holding Value $173k 15,500 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$218k 15,500 shares
$14.04
$11.13
Verve Therapeutics
Verve Therapeutics VERV
Director
Holding Value $208k 18,700 shares
Last Trade
May 12, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$122k 10,000 shares
$12.15
$11.13
Verve Therapeutics
Verve Therapeutics VERV
Director
Holding Value $96.8k 8,700 shares
Last Trade
Mar 15, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$85.5k 4,000 shares
$21.38
$11.13
Verve Therapeutics
Verve Therapeutics VERV
Director
Holding Value $52.3k 4,700 shares
Last Trade
Dec 02, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$147k 4,700 shares
$31.34
$11.13
Verve Therapeutics
Verve Therapeutics VERV
10% owner
Holding Value $0 0 shares
Last Trade
Jun 16, 2021 Sale
No data
No data
$11.13
Astria Therapeutics
Astria Therapeutics ATXS
Director
Holding Value $94.4k 7,500 shares
Last Trade
Jun 11, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$12.58
Catabasis Pharmaceuticals
Catabasis Pharmaceuticals CATB
Director
Holding Value $64.1k 7,500 shares
Last Trade
Jun 11, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$278k 7,500 shares
$37.02
$8.54
Astria Therapeutics
Astria Therapeutics ATXS
Director
Holding Value $94.4k 7,500 shares
Last Trade
Jun 04, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$12.58
Catabasis Pharmaceuticals
Catabasis Pharmaceuticals CATB
Director
Holding Value $64.1k 7,500 shares
Last Trade
Jun 04, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$294k 7,500 shares
$39.18
$8.54
Catabasis Pharmaceuticals
Catabasis Pharmaceuticals CATB
Director
Holding Value $120k 14,000 shares
Last Trade
Jun 07, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.24M 14,000 shares
$88.80
$8.54
Astria Therapeutics
Astria Therapeutics ATXS
Director
Holding Value $176k 14,000 shares
Last Trade
Jun 07, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$12.58
Catabasis Pharmaceuticals
Catabasis Pharmaceuticals CATB
Director
Holding Value $55.5k 6,500 shares
Last Trade
Jul 27, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$495k 6,500 shares
$76.20
$8.54
Astria Therapeutics
Astria Therapeutics ATXS
Director
Holding Value $81.8k 6,500 shares
Last Trade
Jul 27, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$12.58
Catabasis Pharmaceuticals
Catabasis Pharmaceuticals CATB
Director
Holding Value $55.5k 6,500 shares
Last Trade
Jul 27, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$495k 6,500 shares
$76.20
$8.54

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up